Consulting & Advisory

Health Check

A UK-crypto asset subsidiary of a Nasdaq-listed firm in the U.S. has a requirement to review their anti-money laundering (AML) policy framework and idetify possible gaps in line with FCA requirements.

The Client

UK-crypto asset subsidiary of a Nasdaq-listed firm in the United States.

The Challenge

This called for a health check which consists of a high-level review of the design of a firm’s FC framework to identify problem areas.

The Solution

Lysis reviewed the client’s policy framework and made recommendations for uplifting the policies based on identified gaps. From a content perspective, this included a review to determine if the policies are documented and aligned with the firm’s standards across all the business sectors.Testing of the controls can only take place once all the policy recommendations were embedded into the client’s policy framework. Ineffective policies by design will result in ineffective implementation and this will impact the testing of controls negatively.


Lysis provided the client with a detailed report that contained the findings of the review. The report helped the firm to conduct a gap analysis against their current approach to AML and current regulatory requirements which allowed the firm to gain a detailed and independent understanding of its AML governance framework.

Ready to chat about how we can help you?
Get in touch today!
Get in Touch
More Case Studies
Browse Case Studies
Consulting & Advisory
White labelling strategy and business case
Operations & Resourcing
Transaction Monitoring and KYC resourcing
Operations & Resourcing
Screening Managed Service

Offices across the globe.